Ageo, Japan

Hidemi Shimizu


Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 66(Granted Patents)


Location History:

  • Ageo, JA (1977 - 1978)
  • Tokyo, JP (1978)

Company Filing History:


Years Active: 1977-1978

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Hidemi Shimizu

Introduction

Hidemi Shimizu, an accomplished inventor based in Ageo, Japan, has made significant contributions to the field of pharmaceuticals. With a total of four patents to her name, Shimizu's work centers around the advancements in drug formulation and stabilization techniques.

Latest Patents

One of Shimizu's latest notable patents is the "Stabilized oral prostaglandin formulation and the process for the preparation." This patent details a dry, stabilized oral pharmaceutical formulation containing a prostaglandin E group, which is prepared from a lyophilized composition that includes a prostaglandin E group and various additives such as thiol compounds, dextrin, dextran, lower alkyl cellulose, and water-soluble salts of deoxycholic acid. Additionally, another significant patent focuses on the "Process of preparing stable prostaglandin E group-containing formulation," where the method involves adding specific additives to a prostaglandin E group and subjecting the mixture to lyophilization, ensuring the formulation's stability and efficacy.

Career Highlights

Hidemi Shimizu has dedicated her career to advancing pharmaceutical sciences while working at Yamanouchi Pharmaceutical Company Ltd. Her innovative approach has led to breakthroughs that enhance the stability and effectiveness of medical formulations, positioning her as a key figure in pharmaceutical research and development.

Collaborations

Throughout her career, Shimizu has collaborated with esteemed colleagues such as Kiyoshi Okazaki and Jun Sekino. These partnerships have fostered an environment of innovation, contributing to the successful development of her patented formulations.

Conclusion

Hidemi Shimizu's pioneering work in the stabilization of pharmaceutical formulations highlights the critical intersection of innovation and healthcare. Her contributions not only reflect her expertise but also promise to enhance the quality and effectiveness of therapeutic applications in the pharmaceutical industry. As she continues to explore new avenues for development, Shimizu stands as an inspiring example of ingenuity in modern science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…